Bennett Associates Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$885K Sell
765
-38
-5% -$44.8K 0.54% 25
2026
Q2
$963K Buy
803
+137
+21% +$140K 0.6% 23
2026
Q1
$613K Buy
666
+224
+51% +$227K 0.41% 27
2025
Q4
$475K Buy
442
+133
+43% +$127K 0.33% 32
2025
Q3
$236K Buy
+309
New +$230K 0.17% 45

Other funds holding LLY

Bennett Associates Wealth Management's LLY Position: Q3 2026 in Review

Bennett Associates Wealth Management reduced its Eli Lilly (LLY) stake by 4.7% in Q3 2026, selling an estimated $44.8K and leaving 765 shares worth $885K. The position accounts for 0.54% of the portfolio, ranked #25.

Bennett Associates Wealth Management first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $963K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bennett Associates Wealth Management held 765 shares of Eli Lilly worth $885K as of Q3 2026.
  • Bennett Associates Wealth Management sold 38 Eli Lilly shares in Q3 2026, an estimated $44.8K.
  • Eli Lilly made up 0.54% of Bennett Associates Wealth Management's portfolio in Q3 2026, its #25 holding.
  • Bennett Associates Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • Bennett Associates Wealth Management's Eli Lilly position peaked at $963K in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bennett Associates Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.